Parkinson's Disease clinical trials in New York
45 active Parkinson's Disease trials with a site in New York. Describe your situation to see which ones look like a fit.
- A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Disease
- Effects of Osteopathic Manipulative Treatment Protocol on Sleep Quality in Parkinson's Disease Subjects
- Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease
- Rehabilitation of Airway Protection in Parkinson's Disease
- A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- This Clinical Trial is Designed to Evaluate the Safety, Tolerability, Feasibility and Preliminary Efficacy of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in Patients With Parkinson's Disease.
- A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's Disease
- Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
- A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
- Novel Shoe Device NUSHU to Measure Gait Analysis in Parkinson's Patients
- Noise-augmented Automatic Speech Recognition for Speech Treatment in Parkinson's Disease
- A Study of Buntanetap in Participants With PD
- Effects Of Osteopathic Manipulative Medicine(OMM) On Lower Extremity Muscle Characteristics In Parkinson's Disease(PD) Patients
- A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
- RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
- Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:
- A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
- Parkinson's Foundation PD GENEration Genetic Registry
- A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease
- Registry of Deep Brain Stimulation With the VERCISEā¢ System: Vercise DBS Registry
- GBPDC: Gut-Brain in PD Consortium Master Protocol
- Parkinson's Disease Biomarkers in Nerve Cells in the Gut
- PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- Autoimmune Features of Neurodegenerative Disorders
- Abbott DBS Post-Market Study of Outcomes for Indications Over Time
- Deep Brain Stimulation (DBS) Retrospective Outcomes Study
- NYSCF Scientific Discovery Biobank
- Natural History Study of Synucleinopathies
- Speech Learning and Speech Production in Parkinson's Disease
- Virtual Cycling Environments for Persons With Parkinson Disease
- Chronic Transcutaneous Stimulation to Promote Motor Function and Recovery in Individuals With Paralysis or Paresis
- iPACES v3 MCI NIA Protocol Copied for iPACES v4 PD NINDS
- Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage
- Continued Evaluation of Patients With Parkinson's Disease Who Previously Received BRT-DA01
- An Observational Study of Patients With Moderate Parkinson's Disease
- Lithium for Parkinson's: an Extension Trial
- Phase 1/2a Study of ANPD001 in Parkinson Disease
- Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD)
- Study in Parkinson Disease of Exercise
- Drug Discovery for Parkinson's With Mutations in the GBA Gene
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down ā and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest ā what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.